Nada Stefanovic
Overview
Explore the profile of Nada Stefanovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma A, Choi J, Stefanovic N, Al-Sharea A, Simpson D, Mukhamedova N, et al.
Diabetes
. 2020 Dec;
70(3):772-787.
PMID: 33323396
Low-grade persistent inflammation is a feature of diabetes-driven vascular complications, in particular activation of the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome to trigger the maturation and release...
2.
Sharma A, Yuen D, Huet O, Pickering R, Stefanovic N, Bernatchez P, et al.
Vascul Pharmacol
. 2017 Oct;
99:83.
PMID: 28993043
No abstract available.
3.
Sharma A, Rizky L, Stefanovic N, Tate M, Ritchie R, Ward K, et al.
Cardiovasc Diabetol
. 2017 Mar;
16(1):33.
PMID: 28253885
Background: Vascular dysfunction is a pivotal event in the development of diabetes-associated vascular disease. Increased inflammation and oxidative stress are major contributors to vascular dysfunction. Nrf2, a master regulator of...
4.
Rasmiena A, Barlow C, Stefanovic N, Huynh K, Tan R, Sharma A, et al.
Atherosclerosis
. 2016 Nov;
254:314-315.
PMID: 27814884
No abstract available.
5.
Sharma A, Yuen D, Huet O, Pickering R, Stefanovic N, Bernatchez P, et al.
Vascul Pharmacol
. 2015 Nov;
79:32-42.
PMID: 26569096
A critical early event in the pathogenesis of atherosclerosis is vascular inflammation leading to endothelial dysfunction (ED). Reactive oxygen species and inflammation are inextricably linked and declining antioxidant defense is...
6.
Rasmiena A, Barlow C, Stefanovic N, Huynh K, Tan R, Sharma A, et al.
Atherosclerosis
. 2015 Nov;
243(2):598-608.
PMID: 26545014
Background And Aim: We previously reported a negative association of circulating plasmalogens (phospholipids with proposed atheroprotective properties) with coronary artery disease. Plasmalogen modulation was previously demonstrated in animals but its...
7.
Sharma A, Sellers S, Stefanovic N, Leung C, Tan S, Huet O, et al.
Diabetes
. 2015 Jun;
64(11):3937-50.
PMID: 26116699
Patients with diabetes have an increased risk of developing atherosclerosis. Endothelial dysfunction, characterized by the lowered bioavailability of endothelial NO synthase (eNOS)-derived NO, is a critical inducer of atherosclerosis. However,...
8.
Tan S, Sharma A, Stefanovic N, Yuen D, Karagiannis T, Meyer C, et al.
Diabetes
. 2014 Apr;
63(9):3091-103.
PMID: 24740568
Oxidative stress and inflammation are inextricably linked and play essential roles in the initiation and progression of diabetes complications such as diabetes-associated atherosclerosis and nephropathy. Bolstering antioxidant defenses is an...
9.
Tan S, Sharma A, Yuen D, Stefanovic N, Krippner G, Mugesh G, et al.
PLoS One
. 2013 Jul;
8(7):e69193.
PMID: 23874911
Seleno-organic glutathione peroxidase (GPx) mimetics, including ebselen (Eb), have been tested in in vitro studies for their ability to scavenge reactive oxygen and nitrogen species, including hydrogen peroxide and peroxynitrite....
10.
Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock
Huet O, Ramsey D, Miljavec S, Jenney A, Aubron C, Aprico A, et al.
Shock
. 2013 Apr;
39(6):488-94.
PMID: 23603767
With animal models, death as an intentional end point is ethically unacceptable. However, in the study of septic shock, death is still considered the only relevant end point. We defined...